OpenLegislation

Regulation 3 Information

Original text. Later amendments are not shown.

(1)

This regulation applies to any manufacturer or supplier of specified generic health service medicines who—

(a)

holds either a wholesale dealer’s licence within the meaning of section 8(3) of the Medicines Act 1968f1 or a marketing authorisation in respect of those specified generic health service medicines; and

(b)

during the year ended 31st December 2000 supplied generic medicines for health service use to the value of not less than £1,000,000.

(2)

Any holder of a marketing authorisation to whom this regulation applies shall, to the extent that the information is available to him, by 31st January 2002 provide to the Secretary of State the following information in respect of each specified generic health service medicine which was manufactured in accordance with his marketing authorisation during the year ended 31st December 2000—

(a)

the number of packs of each presentation sold by way of wholesale or supplied to persons lawfully conducting pharmacy businesses and dispensing doctors, and

(b)

the receipts from the sales and supplies of each presentation identified separately in respect of receipts from such sale or supply;

(c)

where he did not manufacture the medicines, the identity of the manufacturer and the charges made by him for the manufacture of those medicines;

for the period of 12 months which ended on 31st August 2001.

(3)

Any holder of a wholesale dealer’s licence to whom this regulation applies shall, to the extent that the information is available to him, by 31st January 2002 provide to the Secretary of State in respect of each specified generic health service medicine information on the number of packs of each presentation—

(a)

supplied to persons lawfully conducting pharmacy businesses and dispensing doctors, or

(b)

sold by way of wholesale dealing;

together with information on the receipts from the supplies and sales of each presentation identified separately in respect of receipts from supplies to persons conducting pharmacy businesses, supplies to dispensing doctors and sales by way of wholesale dealing for the period of 12 months which ended on 31st August 2001.

(4)

Where the manufacture, sale or supply of any medicine mentioned in paragraph (2) or (3) was undertaken by more than one company in a group of companies, the information required in respect of that medicine includes information on transactions between those companies which relate to its manufacture, sale, supply and ownership.

(5)

Information given under this regulation shall include information on the amount of any discount or rebate given in respect of each product, or, where discounts and rebates cannot be separately identified, the total value in respect of more than one such product.

Annotations

Footnotes

f1

1968 c. 67 to which there are no relevant amendments.